CAR-T Cell Therapy in First Line for High Risk Diffuse Large B-Cell Lymphoma: Review of Efficacy and CostEffectiveness Against Standard of Care Chemo-Immunotherapy Meeting Abstract

sustainable development goals

publication date

  • November 15, 2022

webpage

published in

start page

  • 12052

end page

  • 12054

volume

  • 140